₹220.42
−5.99%NSE close, 16 Nov 2026
+78.84%
Amanta Healthcare is a small cap company, listed on NSE under the symbol AMANTA. At ₹220.42 a share, the market values the whole company at ₹856 crore.
In FY26, it reported sales of ₹288 crore and a net profit of ₹15 crore, an operating margin of 20.8%.
The market values the company at 46.7 times its profit over the last twelve months and 3.75 times its book value; its return on equity is 8.0% and its borrowings are 0.86 times its equity.
Promoters hold 63.80% of the shares. Foreign institutions hold 0.07%, and domestic institutions, mutual funds among them, 12.20%.
Over the past year the share price has risen 83.5%, and it is 8.9% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
Has submitted its Response on the Spurt in Volume of Security across Exchanges
Significant increase in volume has been observed in Amanta Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written…
Transcript
Disclosure under Regulation 7(2) of the SEBI (Prohibition of InsiderTrading) Regulations, 2015 (the Insider Trading Regulations )
| Expenses |
|---|
| 50.4 |
| 56.2 |
| 59.1 |
| 62.0 |
| 54.3 |
| 65.9 |
| Operating profit | 14.9 | 14.7 | 15.4 | 15.0 | 14.5 | 17.2 |
|---|
| Operating margin | 22.8% | 20.7% | 20.6% | 19.4% | 21.1% | 20.7% |
|---|
| Other income | 1.0 | 0.1 | 0.7 | 1.7 | 0.6 | 0.8 |
|---|
| Interest | 6.3 | 5.2 | 5.1 | 4.3 | 6.0 | 5.8 |
|---|
| Depreciation | 4.6 | 4.7 | 4.7 | 4.8 | 4.7 | 5.3 |
|---|
| Profit before tax | 4.9 | 2.3 | 6.3 | 7.6 | 4.5 | 6.8 |
|---|
| Tax | 1.4 | 1.1 | 1.7 | 2.1 | 1.2 | 2.0 |
|---|
| Net profit | 3.5 | 1.2 | 4.6 | 5.5 | 3.3 | 4.9 |
|---|
| EPS (₹) | 1.22 | 0.35 | 1.35 | 1.61 | 0.85 | 1.25 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 288 |
| Expenses | 228 |
| Operating profit | 59.9 |
| Operating margin | 20.8% |
| Other income | 3.4 |
| Interest | 20.8 |
| Depreciation | 18.7 |
| Profit before tax | 21.1 |
| Tax | 6.3 |
| Net profit | 14.9 |
| EPS (₹) | 4.33 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 48.5 | 20.5 |
| From investing | −93.6 | −48.4 |
| From financing | 126 | −51.5 |
| Spent on fixed assets | −80.2 | −37.6 |
| Free cash flow | −31.7 | −17.1 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 5.2% |
| Operating margin | 20.8% |
| Return on equity | 6.8% |
| Return on capital employed | 9.2% |
| Return on assets | 2.7% |
| Debt to equity | 1.06 |
| Interest coverage | 2.00 |
| Debt to assets | 0.42 |
| Current ratio | 1.69 |
| Quick ratio | 1.10 |
| Cash ratio | 0.57 |
| Asset turnover | 0.52 |
| Fixed asset turnover | 1.46 |
| Inventory turnover | 1.20 |
| Receivables turnover | 6.70 |
| Gross margin | 66.4% |
| Cash from operations to profit | 326.0% |
| Effective tax rate | 29.6% |
Link of Recording
Submission of Monitoring Agency Report for the quarter ended September 30, 2026
Amanta Healthcare Limited announcesQ2 & H1FY27 Results
The financial results for the period ended September 30, 2026.
Schedule of meet
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of InsiderTrading) Regulations, 2015
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of InsiderTrading) Regulations, 2015'.
A copy Srutinizers report of Annual General Meeting held on September 16, 2026. Further, the company has informed the Exchange regarding voting results.